{"id":6887,"date":"2025-09-16T23:03:24","date_gmt":"2025-09-16T23:03:24","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/09\/16\/general-catalyst-wellspan-venture-capital-gapstur-hippocratic\/"},"modified":"2025-09-16T23:03:24","modified_gmt":"2025-09-16T23:03:24","slug":"general-catalyst-wellspan-venture-capital-gapstur-hippocratic","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/09\/16\/general-catalyst-wellspan-venture-capital-gapstur-hippocratic\/","title":{"rendered":"STAT+: How General Catalyst helps a health system invest"},"content":{"rendered":"

STAT+: How General Catalyst helps a health system invest
\n \t

\n
<\/BR>
\n
\n \t

\n
<\/BR><\/p>\n

\n

You\u2019re reading the web edition of STAT\u2019s Health Tech newsletter, our guide to how technology is transforming the life sciences.\u00a0Sign up to get it<\/a>\u00a0delivered in your inbox every Tuesday and Thursday.<\/em><\/p>\n

Reach me: mario.aguilar@statnews.com<\/a><\/p>\n

How General Catalyst helps WellSpan invest<\/h2>\n

WellSpan Health<\/strong> earlier this month announced<\/a> it\u2019s working to develop new health technology applications with General Catalyst<\/strong>\u2019s (GC) HATCo<\/strong>. A closer look at the deal underscores how the health system stands to win both medically and financially through its cozy relationship with the venture capital giant.\u00a0<\/p>\n

Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n

\t

\n
<\/BR>
\n Mario Aguilar
\n \t

\n
<\/BR>
\nGo to statnews<\/a>
\n \t

\n
<\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"

STAT+: How General Catalyst helps a health system invest You\u2019re reading the web edition of STAT\u2019s Health Tech newsletter, our guide to how technology is transforming the life sciences.\u00a0Sign up to get it\u00a0delivered in your inbox every Tuesday and Thursday. Reach me: mario.aguilar@statnews.com How General Catalyst helps WellSpan invest WellSpan Health earlier this month announced […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2194,2217,2318,2212,2176,2152],"tags":[2150],"class_list":["post-6887","post","type-post","status-publish","format-standard","hentry","category-biotech","category-health-tech","category-health-tech-newsletter","category-hospitals","category-pharma","category-stat","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/6887"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=6887"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/6887\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=6887"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=6887"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=6887"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}